Regulatory Crosstalk of Doxorubicin, Estradiol and TNFα Combined Treatment in Breast Cancer-derived Cell Lines

We present a new model of ESR1 network regulation based on analysis of Doxorubicin, Estradiol, and TNFα combination treatment in MCF-7. We used Doxorubicin as a therapeutic agent, TNFα as marker and mediator of an inflammatory microenvironment and 17β-Estradiol (E2) as an agonist of Estrogen Recepto...

Descripción completa

Detalles Bibliográficos
Autores principales: Nassiri, Isar, Inga, Alberto, Meškytė, Erna Marija, Alessandrini, Federica, Ciribilli, Yari, Priami, Corrado
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811586/
https://www.ncbi.nlm.nih.gov/pubmed/31645610
http://dx.doi.org/10.1038/s41598-019-51349-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811586/
https://www.ncbi.nlm.nih.gov/pubmed/31645610
http://dx.doi.org/10.1038/s41598-019-51349-9

Ejemplares similares